Method Comparison of Intelligent Fingerprinting Drug Screening System
NCT07650136 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2026-08-03
Summary
Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
Conditions
- Drug Abuse Illicit
Sponsors & Collaborators
-
Intelligent Bio Solutions Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-06-02
- Primary Completion
- 2026-07-31
- Completion
- 2026-08-31
Countries
- United States
Study Locations
More Related Trials
-
Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
NCT06762379 ·Status: RECRUITING
-
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
NCT00898313 ·Status: RECRUITING
-
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
NCT05219734 ·Status: ACTIVE_NOT_RECRUITING
-
Personalized Breast Cancer Screening
NCT06060938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool
NCT04741503 ·Status: COMPLETED ·Phase: NA
-
Biological Specimen Collection for Laboratory Methods Development and Training Purposes
NCT00025831 ·Status: COMPLETED
-
Bundled Cancer Screening and Genetic Services Navigation
NCT07228000 ·Status: RECRUITING ·Phase: NA
-
Investigation of Urinary Biomarkers for the Detection of Breast Cancer
NCT05453591 ·Status: UNKNOWN ·Phase: NA
-
Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 ·Status: RECRUITING ·Phase: NA
-
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
NCT02213822 ·Status: UNKNOWN
-
Circulating Tumor Cells (CTCs): A Potential Screening Test for Clinically Undetectable Breast Carcinoma
NCT01322750 ·Status: UNKNOWN
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening
NCT05731453 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
NCT00766454 ·Status: COMPLETED
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Oncoliq: Test for Early Breast Cancer Detection.
NCT04906330 ·Status: RECRUITING
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Study to Assess a Diagnostic Aid for Cancer
NCT07046260 ·Status: RECRUITING
-
An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity
NCT07555639 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Healthy Cohort for Early Detection of Cancer
NCT05193305 ·Status: RECRUITING
-
Timing of ctDNA Testing in Advanced Breast Cancer
NCT07681323 ·Status: RECRUITING
-
Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes
NCT03081455 ·Status: COMPLETED
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening
NCT03791008 ·Status: COMPLETED ·Phase: NA
-
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
NCT07069595 ·Status: RECRUITING ·Phase: PHASE2